FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308956250> ?p ?o ?g. }

• W4308956250 endingPage "45" @default.
• W4308956250 startingPage "38" @default.
• W4308956250 abstract "Background: Multi-morbidity poses a substantial challenge for health care in an aging population. Recent studies did not provide evidence for general side effects of anti-cancer therapy regarding the growth rate of coincident abdominal aortic aneurysms, although it was suggested that specific therapeutic substances might accelerate growth. Aneurysm pathology, however, differs with respect to localization. Hence, we present the first ever analysis on the association of cancer and cancer therapy with growth alteration of aneurysms of the ascending aorta (AscAA). Patients and methods: A retrospective single-center identification of AscAA+cancer patients was performed in the institutional picture archiving and communication system (PACS). Included were all patients with ≥2 CT angiograms over ≥6 months and additional malignancy. Clinical data and aneurysm diameters were retrieved and analyzed for an association of cancer (stratified by tumor entity) or cancer therapy (stratified by several classes of chemotherapeutic agents and radiation therapy) with annual growth rate, respectively. Statistics included t-test, Wilcoxon test, and a linear regression model accounting for initial AscAA diameter and type of treatment. Results: From 2003 to 2021, 151 patients (median age 70 years; 85% male) with AscAA and coincident 163 malignancies were identified. Prostate (37%) and hematologic cancer (17%) were most frequent. One-hundred-eleven patients (74%) received chemotherapy and 75 patients (50%) had radiation. After exclusion of six patients with an initial AscAA diameter >55 mm, the average annual AscAA growth rate was 0.18±0.64 mm/year, with only 12 patients experiencing a growth rate >1mm/year. Neither tumor entity nor radiation or chemotherapy - alone or in combination - were significantly associated with an alteration of the annual AscAA growth rate. Likewise, a subanalysis for singular chemotherapeutic agents did not reveal a specific association with AscAA growth alteration. Conclusions: Growth rates of AscAA are low in this cohort with coincident malignancy. Cancer and/or chemotherapy or radiation are not associated with an alteration of the annual growth rate. Additional control examinations seem unnecessary." @default.
• W4308956250 created "2022-11-20" @default.
• W4308956250 creator A5008013075 @default.
• W4308956250 creator A5026396759 @default.
• W4308956250 creator A5036432403 @default.
• W4308956250 creator A5041271319 @default.
• W4308956250 creator A5043546609 @default.
• W4308956250 creator A5050913576 @default.
• W4308956250 creator A5051155569 @default.
• W4308956250 creator A5059538708 @default.
• W4308956250 creator A5060006049 @default.
• W4308956250 creator A5082149404 @default.
• W4308956250 creator A5089935790 @default.
• W4308956250 creator A5064520471 @default.
• W4308956250 date "2023-01-01" @default.
• W4308956250 modified "2023-10-17" @default.
• W4308956250 title "Cancer, cancer treatment and aneurysmatic ascending aorta growth within a retrospective single center study" @default.
• W4308956250 cites W1966949199 @default.
• W4308956250 cites W1982229143 @default.
• W4308956250 cites W1999491158 @default.
• W4308956250 cites W1999728731 @default.
• W4308956250 cites W2004044644 @default.
• W4308956250 cites W2008239726 @default.
• W4308956250 cites W2031104558 @default.
• W4308956250 cites W2033000407 @default.
• W4308956250 cites W2053339527 @default.
• W4308956250 cites W2063054802 @default.
• W4308956250 cites W2085999436 @default.
• W4308956250 cites W2089155702 @default.
• W4308956250 cites W2109760655 @default.
• W4308956250 cites W2112917483 @default.
• W4308956250 cites W2144963994 @default.
• W4308956250 cites W2151276053 @default.
• W4308956250 cites W2155248983 @default.
• W4308956250 cites W2175359709 @default.
• W4308956250 cites W2266821176 @default.
• W4308956250 cites W2275737843 @default.
• W4308956250 cites W2290267539 @default.
• W4308956250 cites W2599026238 @default.
• W4308956250 cites W2737687620 @default.
• W4308956250 cites W2755553574 @default.
• W4308956250 cites W2794781391 @default.
• W4308956250 cites W2888724959 @default.
• W4308956250 cites W2893857728 @default.
• W4308956250 cites W2904158636 @default.
• W4308956250 cites W2936048117 @default.
• W4308956250 cites W3002425056 @default.
• W4308956250 cites W3006438088 @default.
• W4308956250 cites W3086420847 @default.
• W4308956250 cites W3112111534 @default.
• W4308956250 cites W3173560845 @default.
• W4308956250 cites W4210373631 @default.
• W4308956250 cites W4285600183 @default.
• W4308956250 cites W957450740 @default.
• W4308956250 doi "https://doi.org/10.1024/0301-1526/a001038" @default.
• W4308956250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36373268" @default.
• W4308956250 hasPublicationYear "2023" @default.
• W4308956250 type Work @default.
• W4308956250 citedByCount "0" @default.
• W4308956250 crossrefType "journal-article" @default.
• W4308956250 hasAuthorship W4308956250A5008013075 @default.
• W4308956250 hasAuthorship W4308956250A5026396759 @default.
• W4308956250 hasAuthorship W4308956250A5036432403 @default.
• W4308956250 hasAuthorship W4308956250A5041271319 @default.
• W4308956250 hasAuthorship W4308956250A5043546609 @default.
• W4308956250 hasAuthorship W4308956250A5050913576 @default.
• W4308956250 hasAuthorship W4308956250A5051155569 @default.
• W4308956250 hasAuthorship W4308956250A5059538708 @default.
• W4308956250 hasAuthorship W4308956250A5060006049 @default.
• W4308956250 hasAuthorship W4308956250A5064520471 @default.
• W4308956250 hasAuthorship W4308956250A5082149404 @default.
• W4308956250 hasAuthorship W4308956250A5089935790 @default.
• W4308956250 hasConcept C121608353 @default.
• W4308956250 hasConcept C126322002 @default.
• W4308956250 hasConcept C126838900 @default.
• W4308956250 hasConcept C141071460 @default.
• W4308956250 hasConcept C167135981 @default.
• W4308956250 hasConcept C2779399171 @default.
• W4308956250 hasConcept C2908647359 @default.
• W4308956250 hasConcept C509974204 @default.
• W4308956250 hasConcept C71924100 @default.
• W4308956250 hasConcept C99454951 @default.
• W4308956250 hasConceptScore W4308956250C121608353 @default.
• W4308956250 hasConceptScore W4308956250C126322002 @default.
• W4308956250 hasConceptScore W4308956250C126838900 @default.
• W4308956250 hasConceptScore W4308956250C141071460 @default.
• W4308956250 hasConceptScore W4308956250C167135981 @default.
• W4308956250 hasConceptScore W4308956250C2779399171 @default.
• W4308956250 hasConceptScore W4308956250C2908647359 @default.
• W4308956250 hasConceptScore W4308956250C509974204 @default.
• W4308956250 hasConceptScore W4308956250C71924100 @default.
• W4308956250 hasConceptScore W4308956250C99454951 @default.
• W4308956250 hasIssue "1" @default.
• W4308956250 hasLocation W43089562501 @default.
• W4308956250 hasLocation W43089562502 @default.
• W4308956250 hasOpenAccess W4308956250 @default.
• W4308956250 hasPrimaryLocation W43089562501 @default.
• W4308956250 hasRelatedWork W2002120878 @default.

• next